Overview

Evaluating a Pharmacokinetic Drug Interaction Between LGEV1801 and LGEV1802

Status:
Completed
Trial end date:
2019-01-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the drug-drug interaction between LGEV1801 and LGEV1802 in healthy male volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
LG Chem
Treatments:
Ezetimibe
Rosuvastatin Calcium
Valsartan